Showing results (151-160 of 169) with videos related to
Sort By:
Pageof 17
Science Translational Medicine|December 9, 2016
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissionsJacalyn Rosenblatt, Richard M Stone, Lynne Uhl, et al.British Journal of Neurosurgery|May 6, 2023
Aneurysm management in patients over 80 years old with good grade subarachnoid haemorrhageFrederick Ewbank, Samuel Hall, Benjamin Gaastra, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 16, 2020
Haptoglobin genotype and outcome after aneurysmal subarachnoid haemorrhageMatthew J Morton, Isabel C Hostettler, Nabila Kazmi, et al.The New England Journal of Medicine|December 14, 2011
SF3B1 and other novel cancer genes in chronic lymphocytic leukemiaLili Wang, Michael S Lawrence, Youzhong Wan, et al.JCI Insight|October 5, 2018
Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependenciesElisa Ten Hacken, Rebecca Valentin, Fara Faye D Regis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinomaMarkus Riester, Lillian Werner, Joaquim Bellmunt, et al.Acta Neurochirurgica|November 22, 2020
Neurosurgery and coronavirus: impact and challenges-lessons learnt from the first wave of a global pandemicKeyoumars Ashkan, Josephine Jung, Alexandra Maria Velicu, et al.Journal of Neurointerventional Surgery|December 10, 2023
Outcome study of the Pipeline Vantage Embolization Device (second version) in unruptured (and ruptured) aneurysms (PEDVU(R) study)Thomas C Booth, Ahmed Bassiouny, Jeremy Lynch, et al.Cancer Cell|September 22, 2023
ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndromeErin M Parry, Camilla K Lemvigh, Stephanie Deng, et al.Nature Medicine|July 13, 2026
An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trialMatteo S Carlino, Ellen Kapiteijn, Sophie Piperno-Neumann, et al.Pageof 17